Rani Therapeutics Holdings, Inc. (RANI)

NASDAQ: RANI · IEX Real-Time Price · USD

3.870

+0.050 (1.31%)

At close: Jul 2, 2024, 4:00 PM

3.950

+0.080 (2.07%)

After-hours: Jul 2, 2024, 4:52 PM EDT

RANI Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-33.97	-30.59	-8.33	-16.7	-26.59
Depreciation & Amortization	1.86	1.31	0.5	0.59	0.56
Share-Based Compensation	19.01	15.78	22.6	0	0
Other Operating Activities	-38.14	-33.02	-47.01	1.15	-0.24
Operating Cash Flow	-51.24	-46.52	-32.25	-14.96	-26.27
Capital Expenditures	-1.23	-1.62	-0.51	-1.2	-1.53
Change in Investments	31.09	-70.82	0	0	0
Investing Cash Flow	29.86	-72.44	-0.51	-1.2	-1.53
Share Issuance / Repurchase	0.4	0.32	73.67	0	0
Debt Issued / Paid	0	29.31	-4.57	4.04	0
Other Financing Activities	-0.16	-0.63	8.04	68.65	0.85
Financing Cash Flow	0.23	29.01	77.15	72.68	0.85
Net Cash Flow	-21.14	-89.95	44.4	56.52	-26.95
Free Cash Flow	-52.47	-48.13	-32.75	-16.16	-27.8
Free Cash Flow Margin	-	-	-1205.41%	-3497.84%	-2839.53%
Free Cash Flow Per Share	-2.06	-2.02	-1.68	-0.34	-0.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).